BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Free cash flow 2020–2025
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$48.0MFY2025 · since FY2020: -$11.3M → -$48.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.0M | -61.0% |
| FY2024 | -$29.8M | +47.0% |
| FY2023 | -$56.3M | -173.9% |
| FY2022 | -$20.6M | +39.0% |
| FY2021 | -$33.7M | -197.9% |
| FY2020 | -$11.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice